Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence and Booster of Trumenba in Adolescents
NCT01543087Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2012
- Primary completion
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 3 trial of meningococcal group B vaccine in meningococcal group B infection (MenB), sponsored by Pfizer. Started Sep 2012; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal group B infection (MenB)
Beyond the preview
Go deeper on NCT01543087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543087.